活動と実績

学術著書

  1. Umemura Y, Yamakawa K, Hayakawa M, et al. Screening itself for disseminated intravascular coagulation may reduce mortality in sepsis: A nationwide multicenter registry in Japan. Thromb Res.;2018;161:60-66
  2. Kinoshita T, Yamakawa K, Matsuda H, et al. The Survival Benefit of a Novel Trauma Workflow that Includes Immediate Whole-body Computed Tomography, Surgery, and Interventional Radiology, All in One Trauma Resuscitation Room: A Retrospective Historical Control Study. Ann Surg.;2017 Sep 26.[Epub ahead of print]
  3. Nishida T, Kinoshita T, Yamakawa K. Tranexamic acid and trauma-induced coagulopathy. J Intensive Care.;2017;5:5.
  4. Yoshimura J, Kinoshita T, Yamakawa K, et al. Impact of Gram stain results on initial treatment selection in patients with ventilator-associated pneumonia: a retrospective analysis of two treatment algorithms. Crit Care.;2017;21:156.
  5. Terayama T, Yamakawa K, Umemura Y, et al. Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Surg Infect (Larchmt).;2017;18:225-233.
  6. Umemura Y, Yamakawa K, Ogura H, et al. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost.;2016;14:518-30.
  7. Yamakawa K, Umemura Y, Hayakawa M, et al. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan. Crit Care.;2016;20:229.
  8. Hayakawa M, Yamakawa K, Saito S, et al. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study. Thromb Haemost.;2016;115:1157-66.
  9. Kinoshita T, Yoshiya K, Fujimoto Y, et al. Decompressive Craniectomy in Conjunction With Evacuation of Intracranial Hemorrhagic Lesions Is Associated With Worse Outcomes in Elderly Patients With Traumatic Brain Injury: A Propensity Score Analysis. World Neurosurg.;2016;89:187-92.
  10. Umemura Y, Yamakawa K, Kiguchi T, et al. Design and Evaluation of New Unified Criteria for Disseminated Intravascular Coagulation Based on the Japanese Association for Acute Medicine Criteria. Clin Appl Thromb Hemost.;2016;22:153-60.
  11. Yamakawa K, Aihara M, Ogura H, et al. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis. J Thromb Haemost.;2015;13:508-19.
  12. Yoshimura J, Yamakawa K, Ogura H, et al. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Crit Care.;2015;19:78.
  13. Wada D, Nakamori Y, Yamakawa K, et al. Impact on survival of whole-body computed tomography before emergency bleeding control in patients with severe blunt trauma. Crit Care.;2013;17:R178.
  14. Kiguchi T, Nakamori Y, Yamakawa K, et al. Maximal chemiluminescent intensity in response to lipopolysaccharide assessed by endotoxin activity assay on admission day predicts mortality in patients with sepsis. Crit Care Med.;2013;41:1443-9.
  15. Yamakawa K, Ogura H, Fujimi S, et al. Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Intensive Care Med.;2013;39:644-52.
  16. Wada D, Nakamori Y, Yamakawa K, et al. First clinical experience with IVR-CT system in the emergency room: positive impact on trauma workflow. Scand J Trauma Resusc Emerg Med.;2012;20:52.
  17. Ogawa Y, Yamakawa K, Ogura H, et al. Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis. J Trauma Acute Care Surg.;2012;72:1150-7.
  18. Yamakawa K, Tasaki O, Fukuyama M, et al. Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan. BMC Infect Dis.;2011;11:303.
  19. Yamakawa K, Fujimi S, Mohri T, et al. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study. Crit Care.;2011;15:R123.
  20. Yamakawa K, Nakamori Y, Fujimi S, et al. A novel technique of differential lung ventilation in the critical care setting. BMC Res Notes.;2011;4:134.

2017年海外学会発表

  1. Nishida T. Impact of early deep sedation on duration of mechanical ventilation in psychiatric patients requiring intensive care: a retrospective analysis; 37th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium, 2017
  2. Kinoshita T. Development of antibiotic treatment algorithms based on Gram stain to restrict use of broad-spectrum antibiotics in the treatment of ventilator-associated pneumonia: a retrospective analysis; 37th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium, 2017
  3. Kinoshita T. The Survival Benefit of a Novel Trauma Workflow Using the Hybrid ER; The 1st MERIT Symposium: Busan, Korea, 2017 (Invited Speaker)
  4. Hayashi M. THE NOVEL TRAUMA WORK FLOW WITH HYBRID EMERGENCY ROOM SHORTENS THE TIME TO START EMERGENCY SURGERY IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY; 76th Annual Meeting of American Association for the Surgery of Trauma: Baltimore, USA, 2017
  5. Kinoshita T. Novel Trauma Work Flow Using IVR-CT Installed in Trauma Resuscitation Room Improved Mortality in Patients with Severe Torso Injury; American Heart Association Resuscitation Science Symposium: Anaheim, USA, 2017 (Young Investigator Award)
  6. Watanabe A. Predicting High D-dimer Levels by Anatomical Regions and those Severities in Patients with Severe Trauma; American Heart Association Resuscitation Science Symposium: Anaheim, USA, 2017